Center for Psychiatry and Behavioral Medicine

Recent papers from Center for Psychiatry and Behavioral Medicine

1. Clinically Meaningful Within-Patient Change in Core Attention-Deficit/Hyperactivity Disorder Symptoms in Children and Adolescents Treated With Centanafadine: Results From Two Phase 3 Randomized Clinical TrialsJournal of Attention Disorders · 2026
2. Relaxation in action: enhanced vagal modulation during Virabhadrasana (a standing yoga-asana) despite orthostatic demand suggests efficient regulation of effortFrontiers in Human Neuroscience · 2026
3. Treatment Preferences of Physicians of Pediatric Patients with Attention-Deficit/Hyperactivity Disorder in the United States and Canada: A Discrete Choice ExperimentNeurology and Therapy · 2026
4. Efficacy and Safety of Trimodal Dexmethylphenidate (CTx-1301) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Results From a Phase 3, Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled TrialJournal of Child and Adolescent Psychopharmacology · 2026
5. Letter to the Editor: ‘Key links between autistic characteristics and anxiety symptoms in autistic children and youth’: a response to Lai et al. (2026)Child and Adolescent Mental Health · 2026
6. The Impact of Untreated Attention-Deficit/Hyperactivity Disorder on Motor Vehicle Accidents: A Systematic Review and Meta-AnalysisAdvances in Therapy · 2026
7. Efficacy of Centanafadine for Executive Functioning and Learning Problems in Children and Adolescents with Attention-Deficit/Hyperactivity DisorderJournal of Child and Adolescent Psychopharmacology · 2026
8. Chemical and Oxidative Properties of Indoor PM: Discerning the Influence of Typical Building and Source CharacteristicsACS ES&T Air · 2025
9. Prescribing Patterns of Evolocumab and Alirocumab in Patients With Familial Hypercholesterolemia: A Cross-Sectional Study Using the National Ambulatory Medical Care Survey, 2018–2019Cureus · 2025
10. Healthcare Costs Associated with Adverse Events in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder (ADHD): A Claims-Based StudyAdvances in Therapy · 2025
11. Psychological shields in times of risk: the moderating mechanism of psychological capital on anxiety and procrastination among adolescentsInternational Journal of Adolescence and Youth · 2025
12. Pharmacokinetics and Bioequivalence of a Novel Extended-Release Formulation of Methylphenidate Hydrochloride for Attention-Deficit/Hyperactivity Disorder.2025
13. Centanafadine for Attention-Deficit/Hyperactivity Disorder in Adolescents: A Randomized Clinical TrialJournal of the American Academy of Child & Adolescent Psychiatry · 2025
14. Efficacy and Safety of Centanafadine for ADHD Treatment in Children: A Randomized Clinical TrialPediatrics Open Science · 2025
15. A Matching-Adjusted Indirect Comparison (MAIC) of Centanafadine versus Methylphenidate Hydrochloride in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD): Short-Term Safety and Efficacy Outcomes: Comparaison indirecte ajustée par appariement (MAIC) entre centanafadine et le chlorhydrate de méthylphénidate chez les adultes atteints d’un trouble déficitaire de l'attention avec ou sans hyperactivité (TDAH) : Résultats en matière d’innocuité et d’efficacité à court termeThe Canadian Journal of Psychiatry · 2025
16. HIV Preexposure Prophylaxis Service Delivery Models for Emergency Departments: A Qualitative StudyJournal of the International Association of Providers of AIDS Care (JIAPAC) · 2025
17. Viloxazine Extended-Release Administered With Psychostimulants in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Phase 4, Open-Label TrialJournal of Child and Adolescent Psychopharmacology · 2025
18. Safety and Efficacy of Brexpiprazole in the Treatment of Irritability Associated with Autism Spectrum Disorder: An 8-Week, Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial and 26-Week Open-Label Extension in Children and AdolescentsJournal of Child and Adolescent Psychopharmacology · 2025
19. Emergency Department Patients’ Perspectives on Being Offered HIV Pre-Exposure Prophylaxis (PrEP) Services in an Urban ED2025
20. Treatment Preferences of Physicians Treating Adult Patients with Attention-Deficit/Hyperactivity Disorder in the United States and Canada: A Discrete Choice ExperimentNeurology and Therapy · 2024